The firm's US capital Markets department represented during December 2016 two investment banks in four financing rounds


The Capital Markets department represented Aegis Capital Corp. as Lead Placement Agent in an approximately $5 million concurrent registered direct and private placement offering of ordinary shares, debentures and warrants by Rosetta Genomics and in an approximately $12.3 million public offering of common stock by Rennova Health Inc.


In addition the department represented Roth Capital Partners as lead placment Agent in an approximately $5 million sale of convertible notes by Top Image Systems to Hale Capital Partners LP. and in approximately $8.5 public offering by Light Path Technologies.